Overview

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Phase 2 trial to evaluate the safety and potential efficacy of one concentration of deoxycholic acid injection, given in three dosing paradigms, compared to placebo for the reduction of submental fat (fat beneath the chin).
Phase:
Phase 2
Details
Lead Sponsor:
Kythera Biopharmaceuticals
Treatments:
Deoxycholic Acid